High high-sensitivity C-reactive protein/BMI ratio predicts future adverse outcomes in patients with acute coronary syndrome

Coronary Artery Disease
Lei JiaYin Zhang

Abstract

The prognostic value of high-sensitivity C-reactive protein (hsCRP) and obesity in patients with coronary artery disease is controversial. In previous studies, hsCRP was significantly associated with BMI. Thus, we integrated hsCRP and BMI to assess the predictive value in patients with acute coronary syndrome (ACS). In this observational cohort study, 478 patients with ACS were enrolled in Fuwai Hospital from 2010 to 2011,with a mean follow-up of 4.2 years. The endpoint of major adverse cardiovascular events (MACE) was the composite of cardiovascular death, myocardial infarction, revascularization again, heart failure, or stroke. Compared with patients without MACE, we found that patients with MACE had higher hsCRP (3.86 ± 3.66 vs. 3.00 ± 3.17, P = 0.033). Furthermore, we identified that hsCRP was significantly correlated with BMI (r = 0.134, P = 0.005). Thus, hsCRP level was adjusted by BMI to further clarify its role in the prognosis of patients with ACS. According to the tertiles of hsCRP/BMI ratio, the rates of MACE in the lowest tertile group, the median tertile group, and the highest tertile group were 14.0% (21/150), 14.0% (21/150), and 26% (39/150) (P = 0.008), respectively. In multivariate analysis, hsCRP/BMI was indep...Continue Reading

References

Jan 14, 1999·The New England Journal of Medicine·R Ross
Apr 9, 2004·The New England Journal of Medicine·John DaneshVilmundur Gudnason
Jan 7, 2005·The New England Journal of Medicine·Paul M RidkerUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Inv
Jan 11, 2007·Archives of Internal Medicine·Elizabeth SelvinThomas P Erlinger
Jul 9, 2010·The American Journal of Cardiology·Gabriel C BrooksRoger S Blumenthal
Feb 19, 2011·Obesity·Anne L NorrisAaron S Kelly
Nov 23, 2012·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·J ChoiL Pilote
Apr 2, 2015·Circulation·Clive RosendorffUNKNOWN American Heart Association, American College of Cardiology, and American Society of Hypertension
May 21, 2015·Cardiovascular Diabetology·Sohee KimShinae Kang
Mar 15, 2016·Current Atherosclerosis Reports·Taher MandviwalaAnita Deswal
Oct 18, 2016·Current Opinion in Clinical Nutrition and Metabolic Care·Cherlyn DingFaidon Magkos
Feb 2, 2017·Archives of Medical Science : AMS·Hanane Ghomari-BoukhatemMalika Bouchenak
Jun 21, 2018·JAMA : the Journal of the American Medical Association·Craig M HalesCynthia L Ogden

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.